NCT01160211
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Zadzwoń do nas!
Napisz wiadomość
Ul. Roentgena 5
02-781 Warszawa
Copyright © 2011-2019 Via Medica
Wszystkie prawa zastrzeżone.